📰 Alacyclovir News
Page 5 - Alacyclovir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alacyclovir. Real-time updates on events, politics, business and more.
February 9, 2023
The data look quite promising and other treatments have now fallen by the wayside, said Paul Sax, MD, of Brigham and Womens Hospital in Boston.
February 7, 2023
Researchers review the symptoms, diagnosis, and treatment of ocular Mpox syndrome in men living with HIV infection.
February 7, 2023
Pharmaceutical companies that made billions from the pandemic over the past 2 years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely.
February 3, 2023
Additional studies are needed for accurate booster-dose timing as new variants emerge, according to researchers.
February 2, 2023
The FDA announced the changes Wednesday in letters sent to the drugs manufacturers, Pfizer and Merck.
January 19, 2023
COVID-19 continues to hit seniors with disproportionate severity. Experts say Paxlovid is an effective therapy that is being underprescribed for people 65 and older.
January 18, 2023
Evidence suggests Paxlovid can improve COVID-related outcomes, so why arent more physicians, nurse practitioners, physician assistants, and pharmacists prescribing the antiviral combination.
January 11, 2023
Direct-acting antiviral therapy significantly improves liver outcomes, nonliver outcomes, and long-term survival for patients with chronic hepatitis C virus, regardless of disease stage.
January 10, 2023
Pfizer Inc is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, CEO Albert Bourla said.
January 9, 2023
The virus that causes COVID-19 can be found throughout the entire body and remains present for more than 7 months.